regn5715
mAbexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started Jun 3, 2019 (NCT03969849)
Timeline
Indications
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07309432 | Phase 3 | Jan 19, 2026 | Regeneron |
| NCT06602739 | Phase 3 | Oct 15, 2024 | Regeneron |
| NCT05430919 | Phase 2 | Aug 15, 2022 | Regeneron |
| NCT04709575 | Phase 3 | Jan 14, 2021 | Regeneron |
| NCT03969849 | Phase 1 | Jun 3, 2019 | Regeneron |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Regeneron | For profit | 5 | 5 | 3 | 2019 |
1 organizations
Page 1 / 1